These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 3882063

  • 1. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, Sutherland DE.
    Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
    [Abstract] [Full Text] [Related]

  • 2. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Hesse UJ, Fryd DS, Chatterjee SN, Simmons RL, Sutherland DE, Najarian JS.
    Arch Surg; 1986 Sep; 121(9):1056-60. PubMed ID: 3527111
    [Abstract] [Full Text] [Related]

  • 6. Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study.
    Sutherland DE, Fryd DS, So SK, Bentley FR, Ascher NL, Simmons RL, Najarian JS.
    Transplantation; 1984 Dec; 38(6):619-24. PubMed ID: 6390823
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
    Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Fryd DS.
    Transplantation; 1987 Dec; 44(6):775-8. PubMed ID: 3321586
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclosporin A in renal transplantation: a prospective randomized trial.
    Ferguson RM, Rynasiewicz JJ, Sutherland DE, Simmons RL, Najarian JS.
    Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients.
    Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS.
    Transplantation; 1992 Jul; 54(1):50-6. PubMed ID: 1631944
    [Abstract] [Full Text] [Related]

  • 15. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
    Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ.
    Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
    [Abstract] [Full Text] [Related]

  • 16. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G, Walsh G, Deshpande P, Koffman G.
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [Abstract] [Full Text] [Related]

  • 17. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
    Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS.
    Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
    [Abstract] [Full Text] [Related]

  • 18. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
    Hanto DW, Jendrisak MD, So SK, McCullough CS, Rush TM, Michalski SM, Phelan D, Mohanakumar T.
    Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
    [Abstract] [Full Text] [Related]

  • 19. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study.
    Novick AC, Hwei HH, Steinmuller D, Streem SB, Cunningham RJ, Steinhilber D, Goormastic M, Buszta C.
    Transplantation; 1986 Aug; 42(2):154-8. PubMed ID: 3526655
    [Abstract] [Full Text] [Related]

  • 20. [Prospective study of a triple immunosuppressive combination in renal transplantation: cyclosporin A-corticoids-azathioprine].
    Fries D, Kechrid C, Charpentier B, Hammouche M, Moulin B, Rieu P, Neyrat N, Bellamy J, Benoit G.
    Presse Med; 1985 Dec 21; 14(45):2279-82. PubMed ID: 2935811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.